32 years after pioneering prevention of mother-to-child HIV transmission in Europe: achievements, persistent inequities, and the imperative for a coordinated response.
Narcisse Elenga, Albert Faye, Jocelyne Adoissi, Pierre Frange
{"title":"32 years after pioneering prevention of mother-to-child HIV transmission in Europe: achievements, persistent inequities, and the imperative for a coordinated response.","authors":"Narcisse Elenga, Albert Faye, Jocelyne Adoissi, Pierre Frange","doi":"10.1016/j.ijid.2026.109199","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Over the past three decades, Europe has led efforts to prevent mother-to-child transmission of HIV, reducing transmission rates to below 1-2% in many Western and Northern countries. Universal antenatal screening, the early initiation of combination antiretroviral therapy, and integrated obstetric-HIV care have made paediatric HIV largely preventable.</p><p><strong>Main body: </strong>However, national averages obscure persistent inequities within the WHO European Region and inside individual countries. In Eastern Europe and Central Asia, late diagnosis, incomplete screening, and fragmented maternal health services continue to sustain preventable transmission. Even in Western Europe and its overseas territories, subnational and sociodemographic disparities challenge claims of elimination. Structural barriers, including delayed prenatal care, legal insecurity, language barriers, socioeconomic disadvantage, and fragile health systems, remain key determinants of risk. We argue that elimination must be defined not only by national indicators but also by equity, subnational accountability, and harmonised surveillance capable of identifying disparities within the same territory.</p><p><strong>Conclusion: </strong>A response is urgently needed to ensure HIV elimination in all populations.</p><p><strong>Clinical trial number: </strong>not applicable.</p>","PeriodicalId":14006,"journal":{"name":"International Journal of Infectious Diseases","volume":" ","pages":"109199"},"PeriodicalIF":4.6000,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijid.2026.109199","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Over the past three decades, Europe has led efforts to prevent mother-to-child transmission of HIV, reducing transmission rates to below 1-2% in many Western and Northern countries. Universal antenatal screening, the early initiation of combination antiretroviral therapy, and integrated obstetric-HIV care have made paediatric HIV largely preventable.
Main body: However, national averages obscure persistent inequities within the WHO European Region and inside individual countries. In Eastern Europe and Central Asia, late diagnosis, incomplete screening, and fragmented maternal health services continue to sustain preventable transmission. Even in Western Europe and its overseas territories, subnational and sociodemographic disparities challenge claims of elimination. Structural barriers, including delayed prenatal care, legal insecurity, language barriers, socioeconomic disadvantage, and fragile health systems, remain key determinants of risk. We argue that elimination must be defined not only by national indicators but also by equity, subnational accountability, and harmonised surveillance capable of identifying disparities within the same territory.
Conclusion: A response is urgently needed to ensure HIV elimination in all populations.
期刊介绍:
International Journal of Infectious Diseases (IJID)
Publisher: International Society for Infectious Diseases
Publication Frequency: Monthly
Type: Peer-reviewed, Open Access
Scope:
Publishes original clinical and laboratory-based research.
Reports clinical trials, reviews, and some case reports.
Focuses on epidemiology, clinical diagnosis, treatment, and control of infectious diseases.
Emphasizes diseases common in under-resourced countries.